AMEX

iShares Genomics Immunology and Healthcare ETF (IDNA)

401 Thanks from members

The iShares Genomics Immunology and Healthcare ETF (IDNA) exhibits steady market participation within health and biotech equities, featuring a strong NAV total return of 37.62% by August 2026 alongside standard international investment risks.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →